These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
State of incorporation: |
|
I.R.S. Employer Identification No. |
|
Address of Principal Executive Offices: |
|
|
|
|
||||||||||||||||
Telephone Number: |
|
|
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||||||||||||
|
|
|
||||||||||||
|
|
|
|
þ | Accelerated filer | ☐ | Non-accelerated filer | o | ||||||||||||
Smaller reporting company |
|
Emerging growth company |
|
Page Number | ||||||||
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024 | ||||||||
Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2025 and 2024
|
||||||||
Condensed Consolidated Balance Sheets at March 31, 2025 and December 31, 2024 | ||||||||
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024 | ||||||||
Item 6:
|
Exhibits
|
|||||||
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Services | $ |
|
$ |
|
|||||||||||||||||||
Products |
|
|
|||||||||||||||||||||
Financing and other |
|
|
|||||||||||||||||||||
Total revenue |
|
|
|||||||||||||||||||||
Costs and expenses: | |||||||||||||||||||||||
Cost of services |
|
|
|||||||||||||||||||||
Cost of products |
|
|
|||||||||||||||||||||
Cost of financing and other |
|
|
|||||||||||||||||||||
Selling, general and administrative |
|
|
|||||||||||||||||||||
Research and development |
|
|
|||||||||||||||||||||
Restructuring charges |
|
|
|||||||||||||||||||||
Interest expense, net |
|
|
|||||||||||||||||||||
Other components of net pension and postretirement cost |
|
(
|
|||||||||||||||||||||
Other expense |
|
|
|||||||||||||||||||||
Total costs and expenses |
|
|
|||||||||||||||||||||
Income from continuing operations before taxes |
|
|
|||||||||||||||||||||
Provision for income taxes |
|
|
|||||||||||||||||||||
Income from continuing operations
|
|
|
|||||||||||||||||||||
Loss from discontinued operations, net of tax
|
|
(
|
|||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||||||||||||||
Basic earnings (loss) per share:
|
|||||||||||||||||||||||
Continuing operations | $ |
|
$ |
|
|||||||||||||||||||
Discontinued operations |
|
(
|
|||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||||||||||||||
Diluted earnings (loss) per share:
|
|||||||||||||||||||||||
Continuing operations | $ |
|
$ |
|
|||||||||||||||||||
Discontinued operations |
|
(
|
|||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||||||||||||||
Other comprehensive income (loss), net of tax:
|
|||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
|
(
|
|||||||||||||||||||||
Net unrealized loss on cash flow hedges, net of tax of $(
|
|
(
|
|||||||||||||||||||||
Net unrealized gain (loss) on investment securities, net of tax of $
|
|
(
|
|||||||||||||||||||||
Amortization of pension and postretirement costs, net of tax of $
|
|
|
|||||||||||||||||||||
Other comprehensive income (loss), net of tax
|
|
(
|
|||||||||||||||||||||
Comprehensive income (loss)
|
$ |
|
$ |
(
|
March 31, 2025 | December 31, 2024 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Short-term investments (includes $
|
|
|
|||||||||
Accounts and other receivables (net of allowance of $
|
|
|
|||||||||
Short-term finance receivables (net of allowance of $
|
|
|
|||||||||
Inventories |
|
|
|||||||||
Current income taxes |
|
|
|||||||||
Other current assets and prepayments (net of allowance of $
|
|
|
|||||||||
Total current assets |
|
|
|||||||||
Property, plant and equipment, net |
|
|
|||||||||
Rental property and equipment, net |
|
|
|||||||||
Long-term finance receivables (net of allowance of $
|
|
|
|||||||||
Goodwill |
|
|
|||||||||
Intangible assets, net |
|
|
|||||||||
Operating lease assets |
|
|
|||||||||
Noncurrent income taxes |
|
|
|||||||||
Other assets (includes $
|
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||
Current liabilities: | |||||||||||
Accounts payable and accrued liabilities | $ |
|
$ |
|
|||||||
Customer deposits at Pitney Bowes Bank |
|
|
|||||||||
Current operating lease liabilities |
|
|
|||||||||
Current portion of long-term debt |
|
|
|||||||||
Advance billings |
|
|
|||||||||
Current income taxes |
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Long-term debt |
|
|
|||||||||
Deferred taxes on income |
|
|
|||||||||
Tax uncertainties and other income tax liabilities |
|
|
|||||||||
Noncurrent operating lease liabilities |
|
|
|||||||||
Noncurrent customer deposits at Pitney Bowes Bank
|
|
|
|||||||||
Other noncurrent liabilities |
|
|
|||||||||
Total liabilities |
|
|
|||||||||
Commitments and contingencies (See Note 14)
|
|
|
|||||||||
Stockholders’ deficit: | |||||||||||
Common stock, $
|
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||
Treasury stock, at cost (
|
(
|
(
|
|||||||||
Total stockholders’ deficit |
(
|
(
|
|||||||||
Total liabilities and stockholders’ deficit | $ |
|
$ |
|
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||
Loss from discontinued operations, net of tax |
|
|
|||||||||
Adjustments to reconcile net income or loss to net cash from operating activities:
|
|||||||||||
Depreciation and amortization |
|
|
|||||||||
Allowance for credit losses |
|
|
|||||||||
Allowance for DIP Facility
|
(
|
|
|||||||||
Stock-based compensation |
|
|
|||||||||
Amortization of debt fees |
|
|
|||||||||
Loss on debt redemption/refinancing |
|
|
|||||||||
Restructuring charges |
|
|
|||||||||
Restructuring payments |
(
|
(
|
|||||||||
Pension contributions and retiree medical payments |
(
|
(
|
|||||||||
Loss on sale of assets
|
|
|
|||||||||
Loss (gain) on revaluation of intercompany loans |
|
(
|
|||||||||
Other, net |
|
(
|
|||||||||
Changes in operating assets and liabilities, net of acquisitions/divestitures: | |||||||||||
Accounts and other receivables |
(
|
|
|||||||||
Finance receivables |
|
|
|||||||||
Inventories |
(
|
(
|
|||||||||
Other current assets and prepayments |
(
|
(
|
|||||||||
Accounts payable and accrued liabilities |
(
|
(
|
|||||||||
Current and noncurrent income taxes |
|
|
|||||||||
Advance billings |
|
|
|||||||||
Net cash from operating activities - continuing operations |
(
|
(
|
|||||||||
Net cash from operating activities - discontinued operations |
|
(
|
|||||||||
Net cash from operating activities |
(
|
(
|
|||||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures |
(
|
(
|
|||||||||
Purchases of investment securities |
(
|
(
|
|||||||||
Proceeds from sales/maturities of investment securities |
|
|
|||||||||
Net investment in loan receivables |
(
|
(
|
|||||||||
DIP Facility reimbursement |
|
|
|||||||||
Acquisition
|
(
|
|
|||||||||
Other investing activities, net |
|
|
|||||||||
Net cash from investing activities - continuing operations |
(
|
(
|
|||||||||
Net cash from investing activities - discontinued operations |
|
(
|
|||||||||
Net cash from investing activities |
(
|
(
|
|||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from the issuance of debt, net of discount |
|
|
|||||||||
Principal payments of debt |
(
|
(
|
|||||||||
Premiums and fees paid to redeem/refinance debt
|
(
|
|
|||||||||
Dividends paid to stockholders |
(
|
(
|
|||||||||
Customer deposits at Pitney Bowes Bank |
(
|
(
|
|||||||||
Common stock repurchases |
(
|
|
|||||||||
Other financing activities, net |
|
(
|
|||||||||
Net cash from financing activities - continuing operations
|
(
|
(
|
|||||||||
Net cash from financing activities - discontinued operations
|
|
(
|
|||||||||
Net cash from financing activities
|
(
|
(
|
|||||||||
Effect of exchange rate changes on cash and cash equivalents |
|
(
|
|||||||||
Change in cash and cash equivalents |
(
|
(
|
|||||||||
Cash and cash equivalents at beginning of period |
|
|
|||||||||
Cash and cash equivalents at end of period | $ |
|
$ |
|
|||||||
Three Months Ended March 31, 2025 | ||||||||||||||||||||
SendTech Solutions | Presort Services | Other |
Revenue from services and products
|
Revenue from leasing transactions and financing | Total consolidated revenue | |||||||||||||||
Major service/product lines
|
||||||||||||||||||||
Services | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Products |
|
|
|
|
|
|
||||||||||||||
Financing and other |
|
|
|
|
|
|
||||||||||||||
Subtotal |
|
|
|
|
$ |
|
$ |
|
||||||||||||
Revenue from leasing transactions and financing |
|
|
|
|
||||||||||||||||
Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
Timing of revenue recognition from services and products
|
||||||||||||||||||||
Services/products transferred at a point in time
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
Services/products transferred over time
|
|
|
|
|
||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended March 31, 2024 | ||||||||||||||||||||
SendTech Solutions | Presort Services | Other |
Revenue from services and products
|
Revenue from leasing transactions and financing | Total consolidated revenue | |||||||||||||||
Major service/product lines
|
||||||||||||||||||||
Services | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Products |
|
|
|
|
|
|
||||||||||||||
Financing and other |
|
|
|
|
|
|
||||||||||||||
Subtotal |
|
|
|
|
$ |
|
$ |
|
||||||||||||
Revenue from leasing transactions and financing |
|
|
|
|
||||||||||||||||
Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
Timing of revenue recognition from services and products
|
||||||||||||||||||||
Services/products transferred at a point in time
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
Services/products transferred over time
|
|
|
|
|
||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Balance sheet location | March 31, 2025 | December 31, 2024 | Increase/ (decrease) | ||||||||||||||||||||
Advance billings, current | Advance billings | $ |
|
$ |
|
$ |
|
||||||||||||||||
Advance billings, noncurrent | Other noncurrent liabilities | $ |
|
$ |
|
$ |
|
Remainder of 2025 | 2026 | 2027-2030 | Total | |||||||||||||||||||||||
SendTech Solutions | $ |
|
$ |
|
$ |
|
$ |
|
Revenue | |||||||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
SendTech Solutions | $ |
|
$ |
|
|||||||||||||||||||
Presort Services |
|
|
|||||||||||||||||||||
Total segment revenue |
|
|
|||||||||||||||||||||
Other
|
|
|
|||||||||||||||||||||
Total revenue | $ |
|
$ |
|
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
SendTech Solutions | |||||||||||||||||||||||
Revenue | $ |
|
$ |
|
|||||||||||||||||||
Less: | |||||||||||||||||||||||
Cost of revenue |
|
|
|||||||||||||||||||||
Operating expenses
|
|
|
|||||||||||||||||||||
Adjusted segment EBIT | $ |
|
$ |
|
|||||||||||||||||||
Presort Services | |||||||||||||||||||||||
Revenue | $ |
|
$ |
|
|||||||||||||||||||
Less: | |||||||||||||||||||||||
Cost of revenue
|
|
|
|||||||||||||||||||||
Operating expenses
|
|
|
|||||||||||||||||||||
Adjusted segment EBIT | $ |
|
$ |
|
|||||||||||||||||||
Adjusted Segment EBIT | |||||||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
SendTech Solutions | $ |
|
$ |
|
|||||||||||||||||||
Presort Services |
|
|
|||||||||||||||||||||
Total adjusted segment EBIT |
|
|
|||||||||||||||||||||
Reconciliation of adjusted segment EBIT to income from continuing operations before taxes:
|
|||||||||||||||||||||||
Other operations
|
|
|
|||||||||||||||||||||
Interest expense, net |
(
|
(
|
|||||||||||||||||||||
Corporate expenses
|
(
|
(
|
|||||||||||||||||||||
Restructuring charges
|
(
|
(
|
|||||||||||||||||||||
Loss on debt redemption/refinancing |
(
|
|
|||||||||||||||||||||
Foreign currency (loss) gain on intercompany loans |
(
|
|
|||||||||||||||||||||
Benefit in connection with Ecommerce Restructuring
|
|
|
|||||||||||||||||||||
Strategic review costs
|
(
|
(
|
|||||||||||||||||||||
Income from continuing operations before taxes
|
$ |
|
$ |
|
|||||||||||||||||||
Three Months Ended March 31, 2024 | |||||||||||||||||||||||||||||||||||
Revenue | $ |
|
|||||||||||||||||||||||||||||||||
Cost of revenue
|
|
||||||||||||||||||||||||||||||||||
Selling, general and administrative
|
|
||||||||||||||||||||||||||||||||||
Other
|
|
||||||||||||||||||||||||||||||||||
Total costs and expenses
|
|
||||||||||||||||||||||||||||||||||
Loss from discontinued operations before taxes |
(
|
||||||||||||||||||||||||||||||||||
Tax benefit |
(
|
||||||||||||||||||||||||||||||||||
Loss from discontinued operations, net of tax
|
$ |
(
|
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Income from continuing operations
|
$ |
|
$ |
|
|||||||||||||||||||
Loss from discontinued operations, net of tax
|
|
(
|
|||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average shares used in basic EPS
|
|
|
|||||||||||||||||||||
Dilutive effect of common stock equivalents
|
|
|
|||||||||||||||||||||
Weighted-average shares used in diluted EPS |
|
|
|||||||||||||||||||||
Basic earnings (loss) per share:
|
|||||||||||||||||||||||
Continuing operations | $ |
|
$ |
|
|||||||||||||||||||
Discontinued operations |
|
(
|
|||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||||||||||||||
Diluted earnings (loss) per share:
|
|||||||||||||||||||||||
Continuing operations | $ |
|
$ |
|
|||||||||||||||||||
Discontinued operations |
|
(
|
|||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||||||||||||||
Common stock equivalents excluded from calculation of diluted earnings per share because their impact would be anti-dilutive: |
|
|
March 31,
2025 |
December 31,
2024 |
||||||||||
Raw materials | $ |
|
$ |
|
|||||||
Supplies and service parts |
|
|
|||||||||
Finished products |
|
|
|||||||||
Total inventories | $ |
|
$ |
|
March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||
North America | International | Total | North America | International | Total | ||||||||||||||||||||||||||||||
Sales-type lease receivables | |||||||||||||||||||||||||||||||||||
Gross finance receivables | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Unguaranteed residual values |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Unearned income |
(
|
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||
Allowance for credit losses |
(
|
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||
Net investment in sales-type lease receivables |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Loan receivables | |||||||||||||||||||||||||||||||||||
Loan receivables |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Allowance for credit losses |
(
|
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||
Net investment in loan receivables |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Net investment in finance receivables | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Sales-type Lease Receivables | Loan Receivables | ||||||||||||||||||||||||||||||||||
North America | International | Total | North America | International | Total | ||||||||||||||||||||||||||||||
Remainder 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
2026 |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
2027 |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
2028 |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
2029 |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Thereafter |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
March 31, 2025 | |||||||||||||||||||||||||||||
Sales-type Lease Receivables | Loan Receivables | ||||||||||||||||||||||||||||
North America | International | North America | International | Total | |||||||||||||||||||||||||
Past due amounts 0 - 90 days | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Past due amounts > 90 days |
|
|
|
|
|
||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
December 31, 2024 | |||||||||||||||||||||||||||||
Sales-type Lease Receivables | Loan Receivables | ||||||||||||||||||||||||||||
North America | International | North America | International | Total | |||||||||||||||||||||||||
Past due amounts 0 - 90 days | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Past due amounts > 90 days |
|
|
|
|
|
||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Sales-type Lease Receivables | Loan Receivables | ||||||||||||||||||||||||||||
North America | International | North America | International | Total | |||||||||||||||||||||||||
Balance at January 1, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Amounts charged to expense |
|
(
|
|
|
|
||||||||||||||||||||||||
Write-offs |
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
Recoveries |
|
|
|
|
|
||||||||||||||||||||||||
Other |
|
|
|
|
|
||||||||||||||||||||||||
Balance at March 31, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Sales-type Lease Receivables | Loan Receivables | ||||||||||||||||||||||||||||
North America | International | North America | International | Total | |||||||||||||||||||||||||
Balance at January 1, 2024 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Amounts charged to expense |
|
(
|
|
|
|
||||||||||||||||||||||||
Write-offs |
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
Recoveries |
|
|
|
|
|
||||||||||||||||||||||||
Other |
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
Balance at March 31, 2024 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
March 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||
Sales Type Lease Receivables | Loan Receivables | Total | |||||||||||||||||||||||||||||||||||||||||||||
2025 | 2024 | 2023 | 2022 | 2021 | Prior | ||||||||||||||||||||||||||||||||||||||||||
Write-offs | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
March 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||
Sales Type Lease Receivables | Loan Receivables | Total | |||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | 2022 | 2021 | 2020 | Prior | ||||||||||||||||||||||||||||||||||||||||||
Write-offs | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
March 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||
Sales Type Lease Receivables | Loan Receivables | Total | |||||||||||||||||||||||||||||||||||||||||||||
2025 | 2024 | 2023 | 2022 | 2021 | Prior | ||||||||||||||||||||||||||||||||||||||||||
Low | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
Medium |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
High |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Not Scored |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
December 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||
Sales Type Lease Receivables | Loan Receivables | Total | |||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | 2022 | 2021 | 2020 | Prior | ||||||||||||||||||||||||||||||||||||||||||
Low | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
Medium |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
High |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Not Scored |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Profit recognized at commencement | $ |
|
$ |
|
|||||||||||||||||||
Interest income |
|
|
|||||||||||||||||||||
Total lease income from sales-type leases | $ |
|
$ |
|
Remainder 2025 | $ |
|
|||
2026 |
|
||||
2027 |
|
||||
2028 |
|
||||
2029 |
|
||||
Thereafter |
|
||||
Total | $ |
|
March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
||||||||||||||||||||||||||||||
Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
Software & technology |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
Total intangible assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
Remainder 2025 | $ |
|
|||
2026 |
|
||||
2027 |
|
||||
2028 |
|
||||
2029 |
|
||||
Thereafter |
|
||||
Total | $ |
|
December 31, 2024 | Currency impact |
March 31,
2025 |
|||||||||||||||||||||||||||||||||||||||
SendTech Solutions | $ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
Presort Services |
|
|
|
||||||||||||||||||||||||||||||||||||||
Total goodwill | $ |
|
$ |
|
$ |
|
March 31, 2025 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Money market funds | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Equity securities |
|
|
|
|
|||||||||||||||||||
Commingled fixed income securities |
|
|
|
|
|||||||||||||||||||
Government and related securities
|
|
|
|
|
|||||||||||||||||||
Corporate debt securities |
|
|
|
|
|||||||||||||||||||
Mortgage-backed / asset-backed securities |
|
|
|
|
|||||||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
December 31, 2024 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Money market funds | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Equity securities |
|
|
|
|
|||||||||||||||||||
Commingled fixed income securities |
|
|
|
|
|||||||||||||||||||
Government and related securities
|
|
|
|
|
|||||||||||||||||||
Corporate debt securities |
|
|
|
|
|||||||||||||||||||
Mortgage-backed / asset-backed securities |
|
|
|
|
|||||||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
March 31, 2025 | |||||||||||||||||||||||
Amortized cost | Gross unrealized gains | Gross unrealized losses | Estimated fair value | ||||||||||||||||||||
Government and related securities | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
Corporate debt securities |
|
|
(
|
|
|||||||||||||||||||
Commingled fixed income securities |
|
|
(
|
|
|||||||||||||||||||
Mortgage-backed / asset-backed securities |
|
|
(
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
(
|
$ |
|
December 31, 2024 | |||||||||||||||||||||||
Amortized cost | Gross unrealized losses | Estimated fair value | |||||||||||||||||||||
Government and related securities | $ |
|
$ |
(
|
$ |
|
|||||||||||||||||
Corporate debt securities |
|
(
|
|
||||||||||||||||||||
Commingled fixed income securities |
|
(
|
|
||||||||||||||||||||
Mortgage-backed / asset-backed securities |
|
(
|
|
||||||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
Fair Value | Gross unrealized losses | Fair Value | Gross unrealized losses | ||||||||||||||||||||
Greater than 12 continuous months | |||||||||||||||||||||||
Government and related securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Corporate debt securities |
|
|
|
|
|||||||||||||||||||
Commingled fixed income securities |
|
|
|
|
|||||||||||||||||||
Mortgage-backed / asset-backed securities |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Less than 12 continuous months | |||||||||||||||||||||||
Corporate debt securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Commingled fixed income securities |
|
|
|
|
|||||||||||||||||||
Mortgage-backed / asset-backed securities |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Amortized cost | Estimated fair value | ||||||||||
Within 1 year | $ |
|
$ |
|
|||||||
After 1 year through 5 years |
|
|
|||||||||
After 5 years through 10 years |
|
|
|||||||||
After 10 years |
|
|
|||||||||
Total | $ |
|
$ |
|
March 31, 2025 | December 31, 2024 | ||||||||||
Carrying value | $ |
|
$ |
|
|||||||
Fair value | $ |
|
$ |
|
2024 Plan | |||||||||||||||||
Balance at January 1, 2025 | $ |
|
|||||||||||||||
Amounts charged to expense
|
|
||||||||||||||||
Cash payments |
(
|
||||||||||||||||
Noncash activity |
(
|
||||||||||||||||
Balance at March 31, 2025 | $ |
|
|||||||||||||||
2023 Plan | |||||||||||||||||
Balance at January 1, 2024 | $ |
|
|||||||||||||||
Amounts charged to expense - continuing operations
|
|
||||||||||||||||
Amounts charged to expense - discontinued operations
|
|
||||||||||||||||
Cash payments |
(
|
||||||||||||||||
Noncash activity |
(
|
||||||||||||||||
Balance at March 31, 2024 | $ |
|
Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||
2024 Plan | 2023 Plan | ||||||||||||||||||||||||||||||||||
Severance | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
Facilities and other |
|
|
|||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
|
Interest rate | March 31, 2025 | December 31, 2024 | ||||||||||||||
Term loan due March 2026 |
SOFR +
|
$ |
|
$ |
|
||||||||||||
Notes due March 2027 |
|
|
|
||||||||||||||
Notes due March 2028 |
SOFR +
|
|
|
||||||||||||||
Term loan due March 2028 |
SOFR +
|
|
|
||||||||||||||
Term loan due March 2028 |
SOFR +
|
|
|
||||||||||||||
Notes due March 2029 |
|
|
|
||||||||||||||
Term loan due March 2032 |
SOFR +
|
|
|
||||||||||||||
Notes due January 2037 |
|
|
|
||||||||||||||
Notes due March 2043 |
|
|
|
||||||||||||||
Principal amount |
|
|
|||||||||||||||
Less: unamortized costs, net |
|
|
|||||||||||||||
Total debt |
|
|
|||||||||||||||
Less: current portion long-term debt |
|
|
|||||||||||||||
Long-term debt | $ |
|
$ |
|
Defined Benefit Pension Plans | Nonpension Postretirement Benefit Plans | ||||||||||||||||||||||||||||||||||
United States | Foreign | ||||||||||||||||||||||||||||||||||
Three Months Ended | Three Months Ended | Three Months Ended | |||||||||||||||||||||||||||||||||
March 31, | March 31, | March 31, | |||||||||||||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||||
Service cost | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Interest cost |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Expected return on plan assets |
(
|
(
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||
Amortization of prior service (credit) cost |
(
|
(
|
|
|
|
|
|||||||||||||||||||||||||||||
Amortization of net actuarial loss (gain) |
|
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||
Net periodic benefit (income) cost | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Contributions to benefit plans | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Common stock | Retained earnings | Accumulated other comprehensive loss | Treasury stock | Total deficit | |||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2025 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||
Net income | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($
|
— |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock | — |
(
|
— |
|
|
||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2025 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
Common stock | Retained earnings | Accumulated other comprehensive loss | Treasury stock | Total deficit | |||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||
Net loss | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss
|
— | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($
|
— |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock | — |
(
|
— |
|
(
|
||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
Gain (Loss) Reclassified from AOCL | |||||||||||||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Cash flow hedges | |||||||||||||||||||||||
Interest expense, net | $ |
|
$ |
|
|||||||||||||||||||
Income tax provision |
|
|
|||||||||||||||||||||
Net of tax | $ |
|
$ |
|
|||||||||||||||||||
Available-for-sale securities | |||||||||||||||||||||||
Financing revenue | $ |
(
|
$ |
(
|
|||||||||||||||||||
Income tax benefit
|
(
|
(
|
|||||||||||||||||||||
Net of tax | $ |
(
|
$ |
(
|
|||||||||||||||||||
Pension and postretirement benefit plans
|
|||||||||||||||||||||||
Prior service costs | $ |
(
|
$ |
(
|
|||||||||||||||||||
Actuarial losses |
(
|
(
|
|||||||||||||||||||||
Total before tax |
(
|
(
|
|||||||||||||||||||||
Income tax benefit |
(
|
(
|
|||||||||||||||||||||
Net of tax | $ |
(
|
$ |
(
|
Available for sale securities | Pension and postretirement benefit plans | Foreign currency adjustments | Total | ||||||||||||||||||||||||||
Balance at January 1, 2025 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||
Other comprehensive income before reclassifications
|
|
|
|
|
|||||||||||||||||||||||||
Reclassifications into earnings |
|
|
|
|
|||||||||||||||||||||||||
Net other comprehensive income
|
|
|
|
|
|||||||||||||||||||||||||
Balance at March 31, 2025 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Cash flow hedges | Available for sale securities | Pension and postretirement benefit plans | Foreign currency adjustments | Total | |||||||||||||||||||||||||
Balance at January 1, 2024 | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
Other comprehensive income (loss) before reclassifications |
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
Reclassifications into earnings |
(
|
|
|
|
|
||||||||||||||||||||||||
Net other comprehensive (loss) income |
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
Balance at March 31, 2024 | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Three Months Ended March 31, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Balance at beginning of year | $ |
|
$ |
|
|||||||||||||||||||
Amounts charged to expense |
(
|
|
|||||||||||||||||||||
Write-offs, recoveries and other |
(
|
(
|
|||||||||||||||||||||
Balance at end of period | $ |
|
$ |
|
|||||||||||||||||||
Accounts and other receivables | $ |
|
$ |
|
|||||||||||||||||||
Other current assets and prepayments
|
|
|
|||||||||||||||||||||
Total | $ |
|
$ |
|
Three Months Ended March 31, | |||||||||||||||||
2025 | 2024 | ||||||||||||||||
Cash interest paid | $ |
|
$ |
|
|||||||||||||
Cash income tax payments (refunds), net | $ |
|
$ |
(
|
|||||||||||||
Noncash activity | |||||||||||||||||
Capital assets obtained under capital lease obligations | $ |
|
$ |
|
|||||||||||||
Three Months Ended March 31, | |||||||||||||||||||||||
Favorable/(Unfavorable) | |||||||||||||||||||||||
2025 | 2024 | Actual % Change | Constant Currency % change | ||||||||||||||||||||
Total revenue | $ | 493,420 | $ | 521,269 | (5) | % | (5) | % | |||||||||||||||
Cost of revenue | 224,299 | 248,522 | 10 | % | |||||||||||||||||||
Operating expenses | 222,389 | 225,143 | 1 | % | |||||||||||||||||||
Income from continuing operations before taxes | 46,732 | 47,604 | (2) | % | |||||||||||||||||||
Provision for income taxes | 11,310 | 15,500 | 27 | % | |||||||||||||||||||
Income from continuing operations | 35,422 | 32,104 | 10 | % | |||||||||||||||||||
Loss from discontinued operations, net of tax | — | (34,989) | 100 | % | |||||||||||||||||||
Net income (loss) | $ | 35,422 | $ | (2,885) | >100% |
Three Months Ended March 31, | |||||||||||||||||||||||
Favorable/(Unfavorable) | |||||||||||||||||||||||
2025 | 2024 | Actual % change | Constant Currency % change | ||||||||||||||||||||
Services | $ | 123,067 | $ | 128,858 | (4) | % | (4) | % | |||||||||||||||
Products | 93,190 | 114,124 | (18) | % | (18) | % | |||||||||||||||||
Financing and other | 81,798 | 84,455 | (3) | % | (3) | % | |||||||||||||||||
Total revenue | 298,055 | 327,437 | (9) | % | (8) | % | |||||||||||||||||
Cost of services | 37,877 | 42,035 | 10 | % | |||||||||||||||||||
Cost of products | 50,919 | 62,754 | 19 | % | |||||||||||||||||||
Cost of financing and other
|
3,892 | 4,684 | 17 | % | |||||||||||||||||||
Total costs of revenue | 92,688 | 109,473 | 15 | % | |||||||||||||||||||
Gross margin | 205,367 | 217,964 | (6) | % | |||||||||||||||||||
Gross margin % | 68.9 | % | 66.6 | % | |||||||||||||||||||
Selling, general and administrative | 105,098 | 117,026 | 10 | % | |||||||||||||||||||
Research and development | 3,528 | 7,765 | 55 | % | |||||||||||||||||||
Other components of pension and post retirement cost
|
1,807 | (537) | >(100%) | ||||||||||||||||||||
Adjusted Segment EBIT | $ | 94,934 | $ | 93,710 | 1 | % |
Three Months Ended March 31, | |||||||||||||||||||||||
Favorable/(Unfavorable) | |||||||||||||||||||||||
2025 | 2024 | Actual % Change | Constant Currency % change | ||||||||||||||||||||
Services | $ | 177,814 | $ | 169,807 | 5 | % | 5 | % | |||||||||||||||
Cost of services | 104,635 | 107,327 | 3 | % | |||||||||||||||||||
Gross Margin | 73,179 | 62,480 | 17 | % | |||||||||||||||||||
Gross Margin % | 41.2 | % | 36.8 | % | |||||||||||||||||||
Selling, general and administrative | 18,353 | 22,101 | 17 | % | |||||||||||||||||||
Other components of net pension and postretirement cost
|
47 | 50 | 6 | % | |||||||||||||||||||
Adjusted segment EBIT | $ | 54,779 | $ | 40,329 | 36 | % |
Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||
Favorable/(Unfavorable) | |||||||||||||||||||||||||||||||||||
2025 | 2024 | Actual % change | |||||||||||||||||||||||||||||||||
Corporate expenses
|
$ | 31,903 | $ | 42,202 | 24 | % |
2025 | 2024 | Change | |||||||||||||||
Net cash from operating activities | $ | (16,679) | $ | (12,609) | $ | (4,070) | |||||||||||
Net cash from investing activities | (45,536) | (11,841) | (33,695) | ||||||||||||||
Net cash from financing activities | (85,066) | (58,433) | (26,633) | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | 1,342 | (2,147) | 3,489 | ||||||||||||||
Change in cash and cash equivalents | $ | (145,939) | $ | (85,030) | $ | (60,909) |
Total number of
shares purchased |
Average price
paid per share |
Total number of
shares purchased as part of publicly announced plans or programs |
Approximate
dollar value of shares that may yet be purchased under the plans or programs (in thousands) |
||||||||||||||||||||
Beginning balance | $150,000 | ||||||||||||||||||||||
January 2025 | — | $ | — | — | $150,000 | ||||||||||||||||||
February 2025 | 244,929 | $ | 10.73 | 244,929 | $147,373 | ||||||||||||||||||
March 2025 | 1,291,036 | $ | 9.58 | 1,291,036 | $135,000 | ||||||||||||||||||
1,535,965 | $ | 9.77 | 1,535,965 |
Action
|
Date
|
Trading Arrangement
|
Total Shares to be Sold
(3)
|
Expiration Date
|
||||||||||||||||
Rule 10b5-1
(1)
|
Non-Rule 10b5-1
(2)
|
|||||||||||||||||||
|
Adopt
|
|
|
|
|
|||||||||||||||
Exhibit
Number |
Description | Exhibit Number in this Form 10-Q | |||||||||
3.1 | 3.2 | ||||||||||
3.2 | 3.4 | ||||||||||
10.1 | 10.1 | ||||||||||
10.2*
|
10.2 | ||||||||||
10.3*
|
10.3 | ||||||||||
31.1 | 31.1 | ||||||||||
31.2 | 31.2 | ||||||||||
32.1 | 32.1 | ||||||||||
32.2 | 32.2 | ||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||||||||
101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document | ||||||||||
101.DEF | Inline XBRL Taxonomy Definition Linkbase Document | ||||||||||
101.LAB | Inline XBRL Taxonomy Label Linkbase Document | ||||||||||
101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document | ||||||||||
104 | The cover page from the Company's Quarterly Report on Form 10-Q for the current quarter, formatted in Inline XBRL. (included as Exhibit 101). |
PITNEY BOWES INC. | ||||||||
Date: | May 8, 2025 | |||||||
/s/ Robert J. Gold
|
||||||||
Robert J. Gold
|
||||||||
Executive Vice President and Chief Financial Officer
|
||||||||
(Duly Authorized Officer, Principal Financial Officer) | ||||||||
/s/ Lauren Thomas DeFina | ||||||||
Lauren Thomas DeFina | ||||||||
Vice President and Chief Accounting Officer | ||||||||
(Duly Authorized Officer, Principal Accounting Officer) |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Telephone and Data Systems, Inc. | TDS |
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|